Does  ||| S:0 E:5 ||| VBZ
stent  ||| S:5 E:11 ||| VBN
implantation  ||| S:11 E:24 ||| RB
improve  ||| S:24 E:32 ||| VB
the  ||| S:32 E:36 ||| DT
result  ||| S:36 E:43 ||| NN
of  ||| S:43 E:46 ||| IN
repeat  ||| S:46 E:53 ||| NN
embolization  ||| S:53 E:66 ||| NN
in  ||| S:66 E:69 ||| IN
recanalized  ||| S:69 E:81 ||| JJ
aneurysms ||| S:81 E:90 ||| NN
?  ||| S:90 E:92 ||| .
Although  ||| S:92 E:101 ||| IN
endovascular  ||| S:101 E:114 ||| JJ
technique  ||| S:114 E:124 ||| NN
and  ||| S:124 E:128 ||| CC
related  ||| S:128 E:136 ||| JJ
devices  ||| S:136 E:144 ||| NNS
continue  ||| S:144 E:153 ||| VBP
to  ||| S:153 E:156 ||| TO
improve ||| S:156 E:163 ||| VB
,  ||| S:163 E:165 ||| ,
recanalization  ||| S:165 E:180 ||| VBG
of  ||| S:180 E:183 ||| IN
embolized  ||| S:183 E:193 ||| JJ
aneurysm  ||| S:193 E:202 ||| NN
remains  ||| S:202 E:210 ||| VBZ
a  ||| S:210 E:212 ||| DT
pitfall  ||| S:212 E:220 ||| NN
of  ||| S:220 E:223 ||| IN
this  ||| S:223 E:228 ||| DT
approach ||| S:228 E:236 ||| NN
.  ||| S:236 E:238 ||| .
The  ||| S:238 E:242 ||| DT
problem  ||| S:242 E:250 ||| NN
of  ||| S:250 E:253 ||| IN
how  ||| S:253 E:257 ||| WRB
to  ||| S:257 E:260 ||| TO
treat  ||| S:260 E:266 ||| VB
the  ||| S:266 E:270 ||| DT
recanalized  ||| S:270 E:282 ||| JJ
aneurysm  ||| S:282 E:291 ||| NN
needs  ||| S:291 E:297 ||| VBZ
to  ||| S:297 E:300 ||| TO
be  ||| S:300 E:303 ||| VB
addressed ||| S:303 E:312 ||| VBN
.  ||| S:312 E:314 ||| .
To  ||| S:314 E:317 ||| TO
determine  ||| S:317 E:327 ||| VB
the  ||| S:327 E:331 ||| DT
outcomes  ||| S:331 E:340 ||| NN
of  ||| S:340 E:343 ||| IN
patients  ||| S:343 E:352 ||| NNS
undergoing  ||| S:352 E:363 ||| VBG
repeat  ||| S:363 E:370 ||| NN
embolization  ||| S:370 E:383 ||| NN
for  ||| S:383 E:387 ||| IN
recanalized  ||| S:387 E:399 ||| JJ
intracranial  ||| S:399 E:412 ||| JJ
aneurysms  ||| S:412 E:422 ||| NN
and  ||| S:422 E:426 ||| CC
to  ||| S:426 E:429 ||| TO
evaluate  ||| S:429 E:438 ||| VB
the  ||| S:438 E:442 ||| DT
impact  ||| S:442 E:449 ||| NN
of  ||| S:449 E:452 ||| IN
stent  ||| S:452 E:458 ||| JJ
implantation  ||| S:458 E:471 ||| NN
on  ||| S:471 E:474 ||| IN
subsequent  ||| S:474 E:485 ||| JJ
recanalization ||| S:485 E:499 ||| NN
.  ||| S:499 E:501 ||| .
Between  ||| S:501 E:509 ||| IN
September  ||| S:509 E:519 ||| NNP
2001  ||| S:519 E:524 ||| CD
and  ||| S:524 E:528 ||| CC
September  ||| S:528 E:538 ||| NNP
2011 ||| S:538 E:542 ||| CD
,  ||| S:542 E:544 ||| ,
we  ||| S:544 E:547 ||| PRP
performed  ||| S:547 E:557 ||| VBD
endovascular  ||| S:557 E:570 ||| JJ
retreatment  ||| S:570 E:582 ||| NN
in  ||| S:582 E:585 ||| IN
162  ||| S:585 E:589 ||| CD
patients  ||| S:589 E:598 ||| NNS
with  ||| S:598 E:603 ||| IN
a  ||| S:603 E:605 ||| DT
total  ||| S:605 E:611 ||| NN
of  ||| S:611 E:614 ||| IN
197  ||| S:614 E:618 ||| CD
recanalized  ||| S:618 E:630 ||| CD
intracranial  ||| S:630 E:643 ||| CD
aneurysms ||| S:643 E:652 ||| NNS
.  ||| S:652 E:654 ||| .
Stent  ||| S:654 E:660 ||| JJ
implantation  ||| S:660 E:673 ||| NN
was  ||| S:673 E:677 ||| VBD
performed  ||| S:677 E:687 ||| VBN
in  ||| S:687 E:690 ||| IN
68  ||| S:690 E:693 ||| CD
aneurysms  ||| S:693 E:703 ||| NN
during  ||| S:703 E:710 ||| IN
the  ||| S:710 E:714 ||| DT
retreatment ||| S:714 E:725 ||| NN
.  ||| S:725 E:727 ||| .
Clinical  ||| S:727 E:736 ||| JJ
and  ||| S:736 E:740 ||| CC
morphological  ||| S:740 E:754 ||| JJ
outcomes  ||| S:754 E:763 ||| NNS
were  ||| S:763 E:768 ||| VBD
assessed  ||| S:768 E:777 ||| VBN
at  ||| S:777 E:780 ||| IN
6  ||| S:780 E:782 ||| CD
months  ||| S:782 E:789 ||| NNS
or  ||| S:789 E:792 ||| CC
more  ||| S:792 E:797 ||| JJR
after  ||| S:797 E:803 ||| IN
repeat  ||| S:803 E:810 ||| NN
embolization ||| S:810 E:822 ||| NN
.  ||| S:822 E:824 ||| .
Procedure-related  ||| S:824 E:842 ||| JJ
complications ||| S:842 E:855 ||| NNS
,  ||| S:855 E:857 ||| ,
including  ||| S:857 E:867 ||| VBG
asymptomatic  ||| S:867 E:880 ||| JJ
thromboembolism ||| S:880 E:895 ||| NN
,  ||| S:895 E:897 ||| ,
occurred  ||| S:897 E:906 ||| VBD
with  ||| S:906 E:911 ||| IN
15  ||| S:911 E:914 ||| CD
aneurysms  ||| S:914 E:924 ||| NNS
( ||| S:924 E:925 ||| -LRB-
7.6 ||| S:925 E:928 ||| CD
% ||| S:928 E:929 ||| NN
)  ||| S:929 E:931 ||| -RRB-
without  ||| S:931 E:939 ||| IN
permanent  ||| S:939 E:949 ||| JJ
neurological  ||| S:949 E:962 ||| JJ
sequelae ||| S:962 E:970 ||| NN
.  ||| S:970 E:972 ||| .
Follow-up  ||| S:972 E:982 ||| JJ
imaging  ||| S:982 E:990 ||| NN
of  ||| S:990 E:993 ||| IN
172  ||| S:993 E:997 ||| CD
aneurysms  ||| S:997 E:1007 ||| NNS
documented  ||| S:1007 E:1018 ||| VBN
stable  ||| S:1018 E:1025 ||| JJ
occlusion  ||| S:1025 E:1035 ||| NN
in  ||| S:1035 E:1038 ||| IN
96  ||| S:1038 E:1041 ||| CD
of  ||| S:1041 E:1044 ||| IN
the  ||| S:1044 E:1048 ||| DT
lesions  ||| S:1048 E:1056 ||| NNS
( ||| S:1056 E:1057 ||| -LRB-
55.8 ||| S:1057 E:1061 ||| CD
% ||| S:1061 E:1062 ||| NN
) ||| S:1062 E:1063 ||| -RRB-
,  ||| S:1063 E:1065 ||| ,
minor  ||| S:1065 E:1071 ||| JJ
recanalization  ||| S:1071 E:1086 ||| NN
in  ||| S:1086 E:1089 ||| IN
17  ||| S:1089 E:1092 ||| CD
( ||| S:1092 E:1093 ||| -LRB-
9.9 ||| S:1093 E:1096 ||| CD
% ||| S:1096 E:1097 ||| NN
) ||| S:1097 E:1098 ||| -RRB-
,  ||| S:1098 E:1100 ||| ,
and  ||| S:1100 E:1104 ||| CC
major  ||| S:1104 E:1110 ||| JJ
recanalization  ||| S:1110 E:1125 ||| NN
in  ||| S:1125 E:1128 ||| IN
59  ||| S:1128 E:1131 ||| CD
( ||| S:1131 E:1132 ||| -LRB-
34.3 ||| S:1132 E:1136 ||| CD
% ||| S:1136 E:1137 ||| NN
)  ||| S:1137 E:1139 ||| -RRB-
during  ||| S:1139 E:1146 ||| IN
the  ||| S:1146 E:1150 ||| DT
mean  ||| S:1150 E:1155 ||| JJ
follow-up  ||| S:1155 E:1165 ||| JJ
period  ||| S:1165 E:1172 ||| NN
of  ||| S:1172 E:1175 ||| IN
26.0  ||| S:1175 E:1180 ||| CD
Â±  ||| S:1180 E:1182 ||| CD
18.0  ||| S:1182 E:1187 ||| CD
months ||| S:1187 E:1193 ||| NNS
.  ||| S:1193 E:1195 ||| .
In  ||| S:1195 E:1198 ||| IN
multiple  ||| S:1198 E:1207 ||| JJ
logistic  ||| S:1207 E:1216 ||| JJ
regression  ||| S:1216 E:1227 ||| JJ
analysis ||| S:1227 E:1235 ||| NN
,  ||| S:1235 E:1237 ||| ,
stent  ||| S:1237 E:1243 ||| JJ
implantation  ||| S:1243 E:1256 ||| NN
was  ||| S:1256 E:1260 ||| VBD
shown  ||| S:1260 E:1266 ||| VBN
to  ||| S:1266 E:1269 ||| TO
reduce  ||| S:1269 E:1276 ||| VB
the  ||| S:1276 E:1280 ||| DT
major  ||| S:1280 E:1286 ||| JJ
recanalization  ||| S:1286 E:1301 ||| JJ
rate  ||| S:1301 E:1306 ||| NN
at  ||| S:1306 E:1309 ||| IN
6  ||| S:1309 E:1311 ||| CD
months  ||| S:1311 E:1318 ||| NNS
after  ||| S:1318 E:1324 ||| IN
retreatment  ||| S:1324 E:1336 ||| NNS
( ||| S:1336 E:1337 ||| -LRB-
odds  ||| S:1337 E:1342 ||| JJ
ratio ||| S:1342 E:1347 ||| NN
:  ||| S:1347 E:1349 ||| :
0.161 ||| S:1349 E:1354 ||| CD
;  ||| S:1354 E:1356 ||| :
95 ||| S:1356 E:1358 ||| CD
%  ||| S:1358 E:1360 ||| NN
confidence  ||| S:1360 E:1371 ||| NN
interval ||| S:1371 E:1379 ||| NNS
: ||| S:1379 E:1380 ||| :
,  ||| S:1380 E:1382 ||| ,
0.038-0.670 ||| S:1382 E:1393 ||| NNP
;  ||| S:1393 E:1395 ||| :
P  ||| S:1395 E:1397 ||| NN
=  ||| S:1397 E:1399 ||| SYM
.012 ||| S:1399 E:1403 ||| CD
)  ||| S:1403 E:1405 ||| -RRB-
and  ||| S:1405 E:1409 ||| CC
thereafter  ||| S:1409 E:1420 ||| RB
( ||| S:1420 E:1421 ||| -LRB-
odds  ||| S:1421 E:1426 ||| JJ
ratio ||| S:1426 E:1431 ||| NN
:  ||| S:1431 E:1433 ||| :
0.226 ||| S:1433 E:1438 ||| CD
;  ||| S:1438 E:1440 ||| :
95 ||| S:1440 E:1442 ||| CD
%  ||| S:1442 E:1444 ||| NN
confidence  ||| S:1444 E:1455 ||| NN
interval ||| S:1455 E:1463 ||| NNS
:  ||| S:1463 E:1465 ||| :
0.088-0.581 ||| S:1465 E:1476 ||| CD
;  ||| S:1476 E:1478 ||| :
P  ||| S:1478 E:1480 ||| NN
=  ||| S:1480 E:1482 ||| SYM
.002 ||| S:1482 E:1486 ||| CD
) ||| S:1486 E:1487 ||| -RRB-
.  ||| S:1487 E:1489 ||| .
Stent  ||| S:1489 E:1495 ||| JJ
implantation ||| S:1495 E:1507 ||| NN
,  ||| S:1507 E:1509 ||| ,
as  ||| S:1509 E:1512 ||| RB
well  ||| S:1512 E:1517 ||| RB
as  ||| S:1517 E:1520 ||| IN
compact  ||| S:1520 E:1528 ||| JJ
coil  ||| S:1528 E:1533 ||| JJ
packing ||| S:1533 E:1540 ||| NN
,  ||| S:1540 E:1542 ||| ,
at  ||| S:1542 E:1545 ||| IN
the  ||| S:1545 E:1549 ||| DT
time  ||| S:1549 E:1554 ||| NN
of  ||| S:1554 E:1557 ||| IN
repeat  ||| S:1557 E:1564 ||| NN
embolization  ||| S:1564 E:1577 ||| NN
seems  ||| S:1577 E:1583 ||| VBZ
beneficial  ||| S:1583 E:1594 ||| JJ
in  ||| S:1594 E:1597 ||| IN
reducing  ||| S:1597 E:1606 ||| VBG
rates  ||| S:1606 E:1612 ||| NNS
of  ||| S:1612 E:1615 ||| IN
further  ||| S:1615 E:1623 ||| JJ
recanalization ||| S:1623 E:1637 ||| NN
.  ||| S:1637 E:1639 ||| .
